Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Description

List of Tables

GlobalData's Medical Devices sector report, "Minimally Invasive Spinal Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Minimally Invasive Spinal Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Minimally Invasive Spinal Devices under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Minimally Invasive Spinal Devices and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Minimally Invasive Spinal Devices under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1864EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Minimally Invasive Spinal Devices Overview

3 Products under Development

3.1 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
3.2 Minimally Invasive Spinal Devices - Pipeline Products by Segment
3.3 Minimally Invasive Spinal Devices - Pipeline Products by Territory
3.4 Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
3.5 Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
3.6 Minimally Invasive Spinal Devices - Ongoing Clinical Trials

4 Minimally Invasive Spinal Devices - Pipeline Products under Development by Companies

4.1 Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
4.2 Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development

5 Minimally Invasive Spinal Devices Companies and Product Overview

6 Minimally Invasive Spinal Devices- Recent Developments

6.1 Oct 08, 2024: SpineGuard Receives 510(K) Clearance For Cannulated PsiFGuard
6.2 Sep 30, 2024: SpineGuard Obtains FDA Clearance for Commercial Release of Its "PsiFGuard" New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion
6.3 Jul 10, 2024: Aurora Spine Corporation to Attend Sixth Annual American Society of Pain & Neuroscience Conference
6.4 Jul 04, 2024: SurGenTec Receives An Additional 510(K) Clearance For Ion Facet Screw System
6.5 May 30, 2024: Partnership With Key Opinion Leaders and Successful Trainings
6.6 Mar 12, 2024: Modified MAGEC X System for Early Onset Scoliosis Treatment Can Now be used in the UK
6.7 Feb 15, 2024: SurGenTec Receives Additional 510(K) Clearance For Ion Facet Screw System
6.8 Dec 12, 2023: ZimVie Announces Compatibility Between its Vital Spinal Fixation System and Brainlab Spine & Trauma Navigation
6.9 Nov 13, 2023: Aurora Spine Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

Product Code: GDME1864EPD

List of Tables

Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
Minimally Invasive Spinal Devices - Pipeline Products by Segment
Minimally Invasive Spinal Devices - Pipeline Products by Territory
Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
Minimally Invasive Spinal Devices - Ongoing Clinical Trials
Minimally Invasive Spinal Devices Companies - Pipeline Products by Stage of Development
Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
Glossary

List of Figures

Minimally Invasive Spinal Devices - Pipeline Products by Stage of Development
Minimally Invasive Spinal Devices - Pipeline Products by Segment
Minimally Invasive Spinal Devices - Pipeline Products by Territory
Minimally Invasive Spinal Devices - Pipeline Products by Regulatory Path
Minimally Invasive Spinal Devices - Pipeline Products by Estimated Approval Date
Minimally Invasive Spinal Devices - Ongoing Clinical Trials